|
Egorin, M J; Yuan, Z M; Sentz, D L et al. (1999) Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother Pharmacol 43:445-53
|
|
Egorin, M J; Rosen, D M; Benjamin, S E et al. (1997) In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene. Cancer Chemother Pharmacol 41:9-14
|
|
Egorin, M J; Sentz, D L; Rosen, D M et al. (1996) Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii. Cancer Chemother Pharmacol 39:51-60
|
|
Eiseman, J L; Yuan, Z M; Eddington, N D et al. (1996) Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice. Cancer Chemother Pharmacol 38:13-20
|
|
Eiseman, J L; Eddington, N D; Leslie, J et al. (1994) Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice. Cancer Chemother Pharmacol 34:465-71
|
|
Leslie, J; Kujawa, J M; Eddington, N et al. (1993) Stability problems with taxol in mouse plasma during analysis by liquid chromatography. J Pharm Biomed Anal 11:1349-52
|
